annual Report 2009 - STRATEC Biomedical AG

More documents

Recommendations

Info

Closely related companies In view of the fact that members of the Leistner family hold a substantial share of the voting rights in both STRATEC Biomedical Systems AG and in DITABIS Digital Biomedical Imaging Systems AG, the latter company is to be deemed a closely related company pursuant to IAS 24. In the year under report, STRATEC AG provided DITABIS Digital Biomedical Imaging Systems AG with services amounting to u 6 thousand (previous year: u 6 thousand) and received services of u 12 thousand (previous year: u 0 thousand). These services were invoiced at prices which would also be agreed with third parties. Subsidiaries In the 2009 financial year, STRATEC Biomedical Systems AG generated revenues of u 12 thousand from transactions with STRATEC NewGen GmbH (previous year: u 32 thousand) and purchased services amounting to u 0 thousand (previous year: u 46 thousand). These services were invoiced at market prices. The profit transfer agreement concluded with STRATEC NewGen GmbH resulted in expenses of u 75 thousand in the year under report (previous year: u 71 thousand). Invitek purchased services amounting to u 11 thousand from STRATEC NewGen GmbH in the 2009 financial year (previous year: u 0 thousand). In the 2009 financial year, STRATEC Biomedical Systems AG generated interest income of u 4 thousand from a loan granted to STRATEC Biomedical Inc. (previous year: u 7 thousand) and generated sales of u 3 thousand with STRATEC Biomedical Inc. (previous year: u 0 thousand). The services purchased by STRATEC Biomedical Systems AG from STRATEC Biomedical Inc. amounted to u 146 thousand (previous year: u 101 thousand). In the 2009 financial year, STRATEC Biomedical Systems AG generated revenues of u 6 thousand (previous year: u 15 thousand) from transactions with STRATEC Biomedical Systems S.R.L., Romania, and purchased services of u 136 thousand (previous year: u 104 thousand). In the 2009 financial year, Robion AG generated revenues of u 24 thousand (previous year: u 0 thousand) from STRATEC Biomedical Systems S.R.L., Romania, and purchased services of u 187 thousand (previous year: u 106 thousand). Sanguin International Ltd., UK, generated sales of u 13 thousand from transactions with Sanguin International Inc., USA, in the period under report (previous year: u 54 thousand). The services purchased by Sanguin International Ltd. from Sanguin International Inc. amounted to u 38 thousand (previous year: u 37 thousand). Receivables and liabilities relating to associates at the balance sheet date have been noted in the respective balance sheet items. Other related parties There were no relationships with other closely related individuals. Contingent liabilities and other financial obligations Other financial obligations primarily relate to acceptance obligations (basic contracts with suppliers concerning modules and contractual obligations to acquire property, plant and equipment, operating leases and development orders) and are structured as follows: in v thousand 2009 2008 Remaining term of up to three years 16,311 17,693 of which remaining term of up to one year 15,157 16,379 108 stratec Annual Report 2009
Report of the board of Management Report of the supervisory board THE share Corporate Governance Group Management report Consolidated financial statements Service There are no other financial obligations with remaining terms of more than three years (previous year: u 359 thousand). There are no contingent liabilities relating to the provision of security for third-party liabilities. Events after the balance sheet date We are not aware of any developments occurring within the STRATEC Group since December 31, 2009, which could have any particular influence on the financial and economic position of the Group. Date of approval for publication The Board of Management of STRATEC AG presented the consolidated financial statements to the Supervisory Board on March 19, 2010. The Supervisory Board will resolve on their approval on March 29, 2010. Birkenfeld, March 19, 2010 STRATEC Biomedical Systems AG The Board of Management Hermann Leistner Marcus Wolfinger Bernd M. Steidle stratec Annual Report 2009 109
Page 1 and 2:
2009 Annual Report
Page 3 and 4:
Key figures at a glance and Locatio
Page 5 and 6:
committed to quality proven partner
Page 7 and 8:
Report of the board of Management R
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
6:50 7:30 7.00 a.m. Getting ready t
Page 15 and 16:
10:38 11:40 8.38 a.m. Talking to th
Page 17 and 18:
3:08 4:12 1.55 p.m. Analyzing the b
Page 19 and 20:
6:55 7:25 4.20 p.m. Getting the res
Page 21 and 22:
10:08 10:20 Just one example of wha
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62: Report of the board of Management R
Page 111: Report of the board of Management R
show all

annual Report 2009 - STRATEC Biomedical AG

Create successful ePaper yourself

Delete template?

Save as template?